- Home
- EAD vs MRK Comparison
EAD vs MRK Comparison
Compare EAD & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EAD | MRK |
|---|---|---|
| Founded | 2003 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 405.4M | 268.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | EAD | MRK |
|---|---|---|
| Price | $6.89 | $108.14 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $114.86 |
| AVG Volume (30 Days) | 178.9K | ★ 11.3M |
| Earning Date | 01-01-0001 | 02-03-2026 |
| Dividend Yield | ★ 8.91% | 3.14% |
| EPS Growth | N/A | ★ 58.08 |
| EPS | N/A | ★ 7.56 |
| Revenue | N/A | ★ $64,235,000,000.00 |
| Revenue This Year | N/A | $1.97 |
| Revenue Next Year | N/A | $4.71 |
| P/E Ratio | ★ N/A | $14.32 |
| Revenue Growth | N/A | ★ 1.68 |
| 52 Week Low | $5.69 | $73.31 |
| 52 Week High | $6.81 | $112.90 |
Technical Indicators
Market Signals| Indicator | EAD | MRK |
|---|---|---|
| Relative Strength Index (RSI) | 61.86 | 54.86 |
| Support Level | $6.77 | $106.93 |
| Resistance Level | $6.89 | $111.97 |
| Average True Range (ATR) | 0.04 | 2.76 |
| MACD | 0.01 | -0.45 |
| Stochastic Oscillator | 89.29 | 33.80 |
Price Performance
Historical ComparisonAbout EAD Allspring Income Opportunities Fund
Allspring Income Opportunities Fund is a diversified closed-end management investment company. Its products and services are mutual funds, closed-end funds, managed accounts services, and variable trust funds. The fund's objective is a high level of current income and capital appreciation. Its portfolio of investments is Commercial services, healthcare services, Food, Pharmaceuticals, Energy, Oil & gas, Pipelines, Diversified financial services, and Others.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).